Results 91 to 100 of about 122,296 (281)

Temporary transfer tattoos and their use in student teaching in dermatology ‐ a monocentric observational study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background The teaching of elementary skin lesions and the ABCDE rule are central components of undergraduate medical education in dermatology. This content is typically taught using photographs, moulages, or patient examples. Independent practice under supervision, however, is often difficult to implement in everyday clinical work ...
Conrad Hempel   +3 more
wiley   +1 more source

Herpes Zoster Ophthalmicus with Third Nerve Palsy

open access: yes, 2013
Images showing presentation of Herpes Zoster (Zoster Ophthalmicus).curriculum_fellow; IC-E5aiv1-herpes-zoster-ophthalmicus-and-its-complications; IC-E10fv4f-herpes-zoster ...
Kathleen B. Digre, MD
core  

Incidence of Herpes Zoster in relationship with Climate Factors from 2009 to 2011

open access: yesAlthea Medical Journal, 2015
Background: Herpes zoster, or shingles, is a skin or mucous infection caused by the reactivation of varicella-zoster virus (VZV). Seasonal pattern of herpes zoster incidence was reported in some countries, indicating that emergence of this disease was ...
Herning Adinda   +2 more
doaj   +1 more source

Herpes zoster in the T1 dermatome presenting with Horner’s syndrome, radicular weakness, and postherpetic neuralgia

open access: yes, 2008
W Oliver Tobin1, Byron R Spencer2, Bart M Demaerschalk21Department of Neurology, Adelaide and Meath Hospital, Dublin, incorporating the National Children’s Hospital, Ireland; 2Department of Neurology, Mayo Clinic Arizona, USAAbstract: Herpes ...
Byron R Spencer   +2 more
core  

Herpes zoster (Shingles) [PDF]

open access: yes, 2018
Herpes zoster or Shingles is caused by varicella-zoster virus (VZV), the same virus that causes chicken-pox (varicella).Primary infection with varicella-zoster virus causes chicken-pox (varicella), then the virus persists in nerve ganglia of sensory but ...
Motswaledi, M.H.   +2 more
core   +1 more source

Ueber den Herpes zoster ophthalmicus

open access: yes, 1871
UEBER DEN HERPES ZOSTER OPHTHALMICUS Franciscus Cornelius Donders Library (-) Ueber den Herpes zoster ophthalmicus (-
Kocks, Joseph
core  

Scalp Dysesthesia: Emerging Pathophysiologic Insights and Therapeutic Implications

open access: yesInternational Journal of Dermatology, EarlyView.
Scalp dysesthesia is a chronic condition diagnosed through exclusion. This scoping review synthesized data from 59 patients to identify recurrent clinical features, comorbidities, and management strategies that may support earlier diagnosis. Emerging patterns suggest that neuronal sensitization may underlie common symptoms.
Aditya K. Gupta   +4 more
wiley   +1 more source

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden   +13 more
wiley   +1 more source

Construction of risk prediction model for postherpetic neuralgia of patients with herpes zoster

open access: yesHuli yanjiu, 2022
ObjectiveTo analyze the risk factors of postherpetic neuralgia(PHN) of patients with herpes zoster and to construct risk prediction model.Methods425 patients with herpes zoster admitted to department of dermatology of our hospital were selected as study ...
LI Jiao, HUANG Guohui, NI Ping
doaj  

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy